Common Contracts
6 similar Underwriting Agreement contracts by CM Life Sciences, Inc., Healthcare Services Acquisition Corp, CM Life Sciences II Inc., Forum Merger II Corp
24,000,000 Units UNDERWRITING AGREEMENTUnderwriting Agreement • February 26th, 2021 • CM Life Sciences II Inc. • Blank checks • New York
HEALTHCARE SERVICES ACQUISITION CORPORATION a Delaware company 28,800,000 Units UNDERWRITING AGREEMENTUnderwriting Agreement • December 30th, 2020 • Healthcare Services Acquisition Corp • Blank checks • New York
HEALTHCARE SERVICES ACQUISITION CORPORATION a Delaware company 30,000,000 Units UNDERWRITING AGREEMENTUnderwriting Agreement • October 20th, 2020 • Healthcare Services Acquisition Corp • Blank checks • New York
Healthcare Services Acquisition Corporation (the “Company”), confirms its agreement with BofA Securities, Inc. (“BofA”) and each of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom BofA is acting as representative (in such capacity, the “Representative”), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of units of the Company set forth in Schedule A hereto and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase all or any part of 4,500,000 additional Units. Each unit (“Unit(s)”) consists of one share of class A common stock, par value $0.0001 (“Class A Common Stock”), and one-half of one redeemable warrant of the Company (“Warrant(s)”). The aforesaid 30,00
38,500,000 Units UNDERWRITING AGREEMENTUnderwriting Agreement • September 4th, 2020 • CM Life Sciences, Inc. • Blank checks • New York
Introductory. CM Life Sciences, Inc., a Delaware corporation (the “Company”), proposes, upon the terms and subject to the conditions set forth in this agreement (this “Agreement”), to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 38,500,000 units of the Company (the “Units”). The 38,500,000 Units to be sold by the Company are called the “Firm Securities.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 5,775,000 Units as provided in Section 2. The additional 5,775,000 Units to be sold by the Company pursuant to such option are collectively called the “Optional Securities.” The Firm Securities and, if and to the extent such option is exercised, the Optional Securities are collectively called the “Offered Securities.” Jefferies LLC has agreed to act as a Representative of the several Underwriters (together in such capacity, the “Representative”) in connection with the offering of the
35,000,000 Units UNDERWRITING AGREEMENTUnderwriting Agreement • August 24th, 2020 • CM Life Sciences, Inc. • Blank checks • New York
20,000,000 Units FORUM MERGER II CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • July 18th, 2018 • Forum Merger II Corp • Blank checks • New York
Introductory. Forum Merger II Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 20,000,000 units of the Company (the “Public Units”). The 20,000,000 Public Units to be sold by the Company are called the “Firm Securities.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 3,000,000 Public Units as provided in Section 2. The additional 3,000,000 Public Units to be sold by the Company pursuant to such option are collectively called the “Optional Securities.” The Firm Securities and, if and to the extent such option is exercised, the Optional Securities are collectively called the “Offered Securities.” Jefferies LLC (“Jefferies”) has agreed to act as the representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering of the Offered Securities for sale to the public as contempla
